93.11
price down icon1.71%   -1.62
after-market アフターアワーズ: 93.50 0.39 +0.42%
loading
前日終値:
$94.73
開ける:
$94.58
24時間の取引高:
64.40M
Relative Volume:
4.63
時価総額:
$235.20B
収益:
$64.17B
当期純損益:
$17.12B
株価収益率:
13.84
EPS:
6.73
ネットキャッシュフロー:
$18.10B
1週間 パフォーマンス:
-1.54%
1か月 パフォーマンス:
+4.03%
6か月 パフォーマンス:
-20.53%
1年 パフォーマンス:
-24.68%
1日の値動き範囲:
Value
$93.07
$94.68
1週間の範囲:
Value
$93.07
$95.43
52週間の値動き範囲:
Value
$81.04
$134.63

Merck Co Inc Stock (MRK) Company Profile

Name
名前
Merck Co Inc
Name
セクター
Healthcare (1165)
Name
電話
908-740-4000
Name
住所
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Name
職員
75,000
Name
Twitter
@Merck
Name
次回の収益日
2025-02-04
Name
最新のSEC提出書
Name
MRK's Discussions on Twitter

MRK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - General icon
MRK
Merck Co Inc
93.11 235.20B 64.17B 17.12B 18.10B 6.73
Drug Manufacturers - General icon
LLY
Lilly Eli Co
837.57 752.28B 45.04B 10.59B 414.30M 11.71
Drug Manufacturers - General icon
ABBV
Abbvie Inc
210.01 370.74B 56.33B 4.28B 17.83B 2.40
Drug Manufacturers - General icon
JNJ
Johnson Johnson
163.63 344.63B 88.82B 14.07B 18.06B 5.79
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
76.86 341.19B 42.09B 14.65B 10.11B 3.2833

Merck Co Inc Stock (MRK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-18 ダウングレード Deutsche Bank Buy → Hold
2025-02-10 ダウングレード TD Cowen Buy → Hold
2025-01-08 ダウングレード Truist Buy → Hold
2024-12-20 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-12-10 再開されました BofA Securities Buy
2024-12-04 アップグレード HSBC Securities Hold → Buy
2024-11-15 開始されました Wolfe Research Peer Perform
2024-11-11 ダウングレード Daiwa Securities Buy → Neutral
2024-10-17 開始されました Bernstein Mkt Perform
2024-03-11 ダウングレード Societe Generale Hold → Sell
2024-01-04 アップグレード TD Cowen Market Perform → Outperform
2023-11-09 開始されました Deutsche Bank Buy
2023-10-27 アップグレード BMO Capital Markets Market Perform → Outperform
2023-10-20 アップグレード UBS Neutral → Buy
2023-07-14 開始されました HSBC Securities Hold
2023-04-13 アップグレード Citigroup Neutral → Buy
2023-03-28 ダウングレード Societe Generale Buy → Hold
2023-03-13 ダウングレード Wells Fargo Overweight → Equal Weight
2023-03-06 開始されました Jefferies Buy
2023-02-22 アップグレード Wolfe Research Peer Perform → Outperform
2023-01-04 アップグレード BofA Securities Neutral → Buy
2022-11-18 開始されました Credit Suisse Outperform
2022-10-10 アップグレード Guggenheim Neutral → Buy
2022-09-14 アップグレード Berenberg Hold → Buy
2022-07-06 アップグレード Daiwa Securities Neutral → Buy
2022-06-06 再開されました SVB Leerink Outperform
2022-04-06 再開されました Morgan Stanley Equal-Weight
2021-12-17 開始されました Goldman Buy
2021-12-16 開始されました Daiwa Securities Neutral
2021-12-13 ダウングレード UBS Buy → Neutral
2021-12-09 開始されました Wells Fargo Overweight
2021-12-07 ダウングレード Guggenheim Buy → Neutral
2021-11-29 ダウングレード Citigroup Buy → Neutral
2021-11-19 開始されました BMO Capital Markets Market Perform
2021-11-01 アップグレード Argus Hold → Buy
2021-09-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-07-27 再開されました Truist Buy
2021-05-20 ダウングレード Argus Buy → Hold
2021-04-07 再開されました RBC Capital Mkts Sector Perform
2020-11-10 再開されました Bernstein Outperform
2020-09-29 開始されました Berenberg Hold
2020-08-03 アップグレード Goldman Neutral → Buy
2020-06-12 ダウングレード Wolfe Research Outperform → Peer Perform
2020-02-27 開始されました Barclays Overweight
2020-01-07 開始されました RBC Capital Mkts Sector Perform
2019-10-17 再開されました BofA/Merrill Neutral
2019-08-16 開始されました SVB Leerink Outperform
2019-07-03 開始されました Mizuho Buy
2019-05-28 開始されました Goldman Neutral
2019-05-13 アップグレード Atlantic Equities Neutral → Overweight
2018-10-16 繰り返されました Citigroup Buy
2018-10-09 再開されました Guggenheim Buy
2018-04-23 アップグレード Goldman Neutral → Buy
2018-04-17 アップグレード Morgan Stanley Equal-Weight → Overweight
2018-04-05 アップグレード Barclays Equal Weight → Overweight
2018-03-12 アップグレード Leerink Partners Mkt Perform → Outperform
2018-02-14 繰り返されました Leerink Partners Mkt Perform
2018-02-07 繰り返されました Morgan Stanley Equal-Weight
2018-01-16 アップグレード SunTrust Hold → Buy
すべてを表示

Merck Co Inc (MRK) 最新ニュース

pulisher
Mar 21, 2025

Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Lyophilized Product Market to Witness Remarkable Growth with - openPR

Mar 21, 2025
pulisher
Mar 20, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel - Bluefield Daily Telegraph

Mar 20, 2025
pulisher
Mar 20, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit - PR Newswire

Mar 20, 2025
pulisher
Mar 20, 2025

Merck & Co., Inc. (MRK): Among Incredibly Cheap Dividend Stock to Buy Now - Insider Monkey

Mar 20, 2025
pulisher
Mar 19, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - GlobeNewswire

Mar 19, 2025
pulisher
Mar 19, 2025

Why Merck & Co. (MRK) Is Among the Most Undervalued Biotech Stocks to Invest In - Yahoo Finance

Mar 19, 2025
pulisher
Mar 19, 2025

Merck & Co., Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your RightsMRK - ACCESS Newswire

Mar 19, 2025
pulisher
Mar 19, 2025

MRK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 19, 2025
pulisher
Mar 18, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - Markets Insider

Mar 18, 2025
pulisher
Mar 18, 2025

Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey

Mar 18, 2025
pulisher
Mar 18, 2025

Merck & Co's Options: A Look at What the Big Money is Thinking - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Class Action Filed Against Merck & Co., Inc. (MRK)April 14, 2025 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 18, 2025
pulisher
Mar 18, 2025

Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued S&P 500 Stock to Buy Now? - Yahoo Finance

Mar 18, 2025
pulisher
Mar 18, 2025

Levi & Korsinsky Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025MRK - PR Newswire

Mar 18, 2025
pulisher
Mar 17, 2025

Is Merck & Co Inc. (NYSE:MRK) the Most Profitable Value Stock to Buy Now? - Insider Monkey

Mar 17, 2025
pulisher
Mar 17, 2025

Shareholders that lost money on Merck & Co., Inc.(MRK) - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming DeadlinesMRK - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 17, 2025
pulisher
Mar 17, 2025

MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

Mar 17, 2025
pulisher
Mar 16, 2025

Merck & Co., Inc. (MRK): Among Top Dividend Contenders List - Yahoo Finance

Mar 16, 2025
pulisher
Mar 16, 2025

2025-03-16 | Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class ActionContact Levi & Korsinsky to Learn More | NYSE:MRK | Press Release - Stockhouse Publishing

Mar 16, 2025
pulisher
Mar 16, 2025

MRK STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 16, 2025
pulisher
Mar 16, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., - GlobeNewswire

Mar 16, 2025
pulisher
Mar 15, 2025

Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

Mar 15, 2025
pulisher
Mar 15, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - GlobeNewswire

Mar 15, 2025
pulisher
Mar 14, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMRK - Markets Insider

Mar 14, 2025
pulisher
Mar 14, 2025

A Closer Look at Merck & Co's Options Market Dynamics - Benzinga

Mar 14, 2025
pulisher
Mar 14, 2025

MRK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 14, 2025
pulisher
Mar 14, 2025

Dividend Roundup: Microsoft, Walmart, Target, Merck & Co, and more - Seeking Alpha

Mar 14, 2025
pulisher
Mar 14, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc. (MRK) Shareholders - ACCESS Newswire

Mar 14, 2025
pulisher
Mar 13, 2025

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph

Mar 13, 2025
pulisher
Mar 13, 2025

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.

Mar 13, 2025
pulisher
Mar 13, 2025

Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK) - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

MRK STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 13, 2025
pulisher
Mar 13, 2025

Merck & Co., Inc. (NYSE:MRK) Looks Interesting, And It's About To Pay A Dividend - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

Merck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025MRK - PR Newswire

Mar 13, 2025
pulisher
Mar 13, 2025

Merck & Co.’s SWOT analysis: pharma giant faces challenges amid keytruda dominance - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Merck & Co., Inc. (NYSE:MRK) Receives $116.39 Consensus Target Price from Analysts - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Kelun Wins World’s First TROP2 ADC Approval In Lung Cancer, Merck Left Out - Citeline News & Insights

Mar 13, 2025
pulisher
Mar 12, 2025

How Do Investors Really Feel About Merck & Co? - Benzinga

Mar 12, 2025
pulisher
Mar 12, 2025

Why Merck & Co., Inc. (MRK) is the Best Pharma Stock to Buy According to Hedge Funds - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Merck releases positive phase 3 data on daily oral HIV drug (MRK:NYSE) - Seeking Alpha

Mar 12, 2025
pulisher
Mar 12, 2025

Merck's Investigational Two-Drug Regimen Maintained HIV-1 Suppression in Late-Stage Trials - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Merck: new treatment option for HIV -March 12, 2025 at 12:16 pm EDT - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Merck & Co., Inc. (MRK): Among Dobermans of the Dow to Buy - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Anti-Inflammatory Therapeutics Market to Reach $125.55 Billion by 2028 | Merck & Co., Inc., GlaxoSmithKline - EIN News

Mar 12, 2025

Merck Co Inc (MRK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_general NVS
$112.13
price down icon 0.95%
$316.04
price up icon 0.32%
drug_manufacturers_general PFE
$26.28
price up icon 0.34%
drug_manufacturers_general SNY
$56.90
price down icon 1.54%
$107.08
price up icon 1.14%
大文字化:     |  ボリューム (24 時間):